These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 24565100)

  • 1. Precipitation in Gallipoli: sugammadex / amiodarone & sugammadex / dobutamine & sugammadex / protamine.
    Hancı V; Kiraz HA; Ömür D; Ekin S; Uyan B; Yurtlu BS
    Braz J Anesthesiol; 2013 Jan; 63(1):163-4. PubMed ID: 24565100
    [No Abstract]   [Full Text] [Related]  

  • 2. Precipitation in Gallipoli: sugammadex / amiodarone & sugammadex / dobutamine & sugammadex / protamine.
    Hancı V; Ali Kiraz H; Ömür D; Ekin S; Uyan B; Yurtlu BS
    Braz J Anesthesiol; 2013; 63(1):163-4. PubMed ID: 23438811
    [No Abstract]   [Full Text] [Related]  

  • 3. Precipitation of sugammadex by protamine.
    Alston TA
    J Clin Anesth; 2011 Nov; 23(7):593. PubMed ID: 22050813
    [No Abstract]   [Full Text] [Related]  

  • 4. Incompatibility of amiodarone hydrochloride and sodium bicarbonate injections.
    Korth-Bradley JM; Ludwig S
    Am J Health Syst Pharm; 1995 Oct; 52(20):2340. PubMed ID: 8564596
    [No Abstract]   [Full Text] [Related]  

  • 5. Incompatibility of amiodarone hydrochloride and evacuated glass bottles.
    Strozyk WR; Williamson R; Thompson D
    Am J Health Syst Pharm; 1996 Jan; 53(2):184. PubMed ID: 8653486
    [No Abstract]   [Full Text] [Related]  

  • 6. [The aqueous formulation of amiodarone i.v. is safer than the formulation available in Spain].
    Montero-Pérez FJ
    Med Clin (Barc); 2011 Jan; 136(1):40. PubMed ID: 19896153
    [No Abstract]   [Full Text] [Related]  

  • 7. Compatibility of amiodarone hydrochloride with vasopressin during simulated Y-site administration.
    Ramaley CC; Li F; Du C
    Int J Pharm Compd; 2013; 17(5):436-8. PubMed ID: 24459790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal behavior study and decomposition kinetics of amiodarone hydrochloride under isothermal conditions.
    Yoshida MI; Gomes EC; Soares CD; Oliveira MA
    Drug Dev Ind Pharm; 2011 Jun; 37(6):638-47. PubMed ID: 21449701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PM101: intravenous amiodarone formulation changes can improve medication safety.
    Souney PF; Cooper WD; Cushing DJ
    Expert Opin Drug Saf; 2010 Mar; 9(2):319-33. PubMed ID: 20074019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M
    Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-specific cyclodextrins with emphasis on sugammadex, the neuromuscular blocker rocuronium and perioperative anaphylaxis: implications for drug allergy.
    Baldo BA; McDonnell NJ; Pham NH
    Clin Exp Allergy; 2011 Dec; 41(12):1663-78. PubMed ID: 21732999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stability of amiodarone hydrochloride in intravenous fluids with 5% glucose].
    Simar G; Detcave C; Godet M; Decoster C; Gillet P; Bihin B; Jamart J; GaLanti LM; Hecq JD
    J Pharm Belg; 2016 Mar; (1):24-25. PubMed ID: 30281220
    [No Abstract]   [Full Text] [Related]  

  • 13. Preclinical pharmacology of sugammadex.
    Bom A; Hope F; Rutherford S; Thomson K
    J Crit Care; 2009 Mar; 24(1):29-35. PubMed ID: 19272536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative inotropic and lusitropic effects of intravenous amiodarone in conscious rats.
    Salgado HC; Simões GM; Santana Filho VJ; Dias da Silva VJ; Salgado MC; Fazan R
    Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):870-5. PubMed ID: 17645632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of sugammadex self-association.
    Kurkov SV; Messner M; Lucassen M; van den Dobbelsteen DJ; den Engelsman J; Loftsson T
    Int J Pharm; 2011 Jul; 413(1-2):134-9. PubMed ID: 21539905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drug sugammadex: a selective relaxant binding agent.
    Welliver M
    AANA J; 2006 Oct; 74(5):357-63. PubMed ID: 17048555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclodextrin-based nonaqueous electrokinetic chromatography with UV and mass spectrometric detection: application to the impurity profiling of amiodarone.
    Mol R; de Jong GJ; Somsen GW
    Electrophoresis; 2008 Sep; 29(17):3575-81. PubMed ID: 18803218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone: an effective antiarrhythmic drug with unusual side effects.
    van Erven L; Schalij MJ
    Heart; 2010 Oct; 96(19):1593-600. PubMed ID: 20837671
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis, free solution capillary electrophoresis separation and toxicity of seven potential impurities of dobutamine.
    Pallavicini M; Pezzetta D; Rossoni G; Valoti E; Villa L
    Arzneimittelforschung; 2001 Jan; 51(1):18-23. PubMed ID: 11215320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colloidal properties of amiodarone in water at low concentration.
    Benedini L; Messina PV; Manzo RH; Allemandi DA; Palma SD; Schulz EP; Frechero MA; Schulz PC
    J Colloid Interface Sci; 2010 Feb; 342(2):407-14. PubMed ID: 19954788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.